详细信息

慢性阻塞性肺疾病共病机制的研究进展    

Research Progress on Comorbidity Mechanisms of Chronic Obstructive Pulmonary Disease

文献类型:期刊文献

中文题名:慢性阻塞性肺疾病共病机制的研究进展

英文题名:Research Progress on Comorbidity Mechanisms of Chronic Obstructive Pulmonary Disease

作者:夏慧静[1];夏晓黎[2];刘文慧[1];马艳萍[2];贺晓芳[1]

第一作者:夏慧静

机构:[1]甘肃中医药大学,甘肃兰州730000;[2]甘肃中医药大学附属医院,甘肃兰州730000

第一机构:甘肃中医药大学

年份:2026

卷号:40

期号:4

起止页码:127

中文期刊名:实用中医内科杂志

外文期刊名:Journal of Practical Traditional Chinese Internal Medicine

基金:甘肃省中医药科研项目(GZ-KP-2022-19);甘肃中医药大学附属医院院内科技项目(gzfy-2021-17);兰州市科技局发展项目(2020-ZD-86)。

语种:中文

中文关键词:慢性阻塞性肺疾病;共病;机制;危险因素

外文关键词:Chronic obstructive pulmonary disease;Comorbidity;Mechanism;Risk factors

摘要:慢性阻塞性肺疾病(Chronic obstructive pulmonary disease,COPD)为临床中常见呼吸系统慢性疾病之一。COPD的发病率和病死率均较高,世界卫生组织预测,到2030年,COPD将成为第3大死因。共病在COPD患者中很常见,也是一个关键的可变因素,并且COPD患者的预后情况受到COPD共病的影响很大。越来越多的证据表明,某些疾病在COPD患者中的发生频率高于一般人群,并且这些合并症显著影响患者结局。因此,在COPD临床诊疗的同时,也应加强对COPD共病的关注。文章回顾了近些年的相关文献,就近年来国内外COPD共病危险因素及发生机制研究进展进行综述,为临床COPD的预防和治疗提供参考。
Chronic obstructive pulmonary disease(COPD)is one of the common chronic respiratory diseases in clinical practice.According to statistics,COPD has a high incidence and mortality rate,and the World Health Organization predicts that it will become the third leading cause of death by 2030.Comorbidity is very common in COPD patients and is also a key variable factor,and the prognosis of COPD patients is greatly affected by COPD comorbidity.There is growing evidence that certain diseases occur more frequently in people with COPD than in the general population,and that these comorbidities significantly affect patient outcomes.Therefore,in the clinical diagnosis and treatment of COPD,we should also pay more attention to COPD comorbidity.The author reviews the research progress of COPD comorbidity risk factors and mechanisms at home and abroad in recent years,so as to provide references for the prevention and treatment of clinical COPD.

参考文献:

正在载入数据...

版权所有©甘肃中医药大学 重庆维普资讯有限公司 渝B2-20050021-8 
渝公网安备 50019002500408号 违法和不良信息举报中心